Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Medical Foods Market: By Route of Administration: Oral, Enteral; By Product Type: Pills, Powders; By Application; By Sales Channel: Online Sales, Institutional Sales, Retail Sales; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Medical Foods Market Outlook

The global medical foods market stood at a value of around USD 21 billion in 2020. The market is further expected to grow at a CAGR of 6.0% in the forecast period of 2021-2026 to attain a value of USD 27.8 billion by 2026.


Increasing Demand for Medical Foods to Treat the Patients Suffering from Diabetic Neuropathy to Aid the Medical Foods Industry Growth

Based on application, the diabetic neuropathy segment is predicted to hold a significant market share in the medical foods industry. This growth can be attributed to the increased incidences of diabetes across the globe. According to the WHO statistics, an estimated 1.5 million people succumbed to diabetes in 2019. In addition, diabetes can also lead to other severe health conditions such as blindness, kidney failure, strokes, and heart attack, among others. Diabetic neuropathy involves nerve damage, which is a direct result of diabetes, wherein keeping the blood sugar under control is essential. In this regard, medical foods are being preferred to help manage the proper diet of patients, as diabetes can be controlled and treated by maintaining a healthy diet, engaging in physical activities, and going for regular medical check-ups. These factors are predicted to enhance the demand for medical foods to treat diabetic neuropathy in the forecast period.


North America to Account for a Significant Market Share in the Global Medical Foods Industry

North America is estimated to hold a significant share of the medical foods industry in the forecast period. This growth can be attributed to the presence of leading market players in the region. The heightened investments in the healthcare industry and the availability of state-of-the-art healthcare infrastructure are also aiding the regional market growth. Moreover, the growing geriatric population with a heightened risk of acquiring diseases is also predicted to bolster the industry growth. The rising disposable incomes and improved living standards are also expected to contribute to the overall market growth in the coming years.


Medical Foods: Industry Definition and Segmentation

Medical foods are specialised foods, which are consumed or enterally administered under the supervision of a medical practitioner. These are generally utilised in specialised dietary management. In addition, medical foods comprise highly purified therapeutic ingredients to provide nutrition and help treat certain diseases or a particular health condition. These foods are modified to add specific nutritional elements based on the medical requirement of patients.

By route of administration, the market is bifurcated into:

  • Oral
  • Enteral

On the basis of product type, the market can be segmented into:

  • Pills
  • Powders
  • Others

Based on application, the industry can be distributed into:

  • Chronic Kidney Disease
  • Minimal Hepatic Encephalopathy
  • Chemotherapy-induced Diarrhea
  • Pathogen Related Infections
  • Diabetic Neuropathy
  • ADHD
  • Depression
  • Alzheimer’s Disease
  • Nutritional Deficiency
  • Orphan Disease
  • Others

Among these, the orphan disease segment can be further divided by type into phenylketonuria, eosinophilic esophagitis, FPIES, and others. 

Based on sales channel, the market can be categorised into:

  • Online Sales 
  • Institutional Sales
  • Retail Sales

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.


Increased Incidences of Chronic Disorders to Augment the Global Medical Foods Industry

The increasing incidences of chronic diseases are anticipated to drive the medical foods industry growth in the coming years. According to the WHO statistics, approximately 17.9 million people succumbed to cardiovascular diseases in 2019, representing 32% of all deaths globally. In addition, a 5% increase was observed in diabetes-related premature deaths between 2000 to 2016. In this regard, medical foods are increasingly being adopted to help meet the nutritional requirements of patients and help reduce their mortality risk. Moreover, the growing geriatric population, which is more susceptible to severe ailments and injury, is also anticipated to propel the demand for medical foods. Furthermore, the rising awareness pertaining to medical foods and the increasing consciousness regarding health and well-being are also predicted to aid the industry growth. These factors are estimated to positively impact the market growth in the forecast period.


Key Industry Players in the Global Medical Foods Market

The report gives a detailed analysis of the following key players in the global medical foods market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Danone S.A
  • Nestle S.A
  • Abbott Nutrition 
  • Targeted Medical Pharma Inc.
  • Primus Pharmaceuticals, Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Medical Foods Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Medical Foods Historical Market (2016-2020) 
    8.3    Global Medical Foods Market Forecast (2021-2026)
    8.4    Global Medical Foods Market by Route of Administration 
        8.4.1    Oral
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Enteral
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
    8.5    Global Medical Foods Market by Product Type
        8.5.1    Pills
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Powders
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Others
    8.6    Global Medical Foods Market by Application
        8.6.1    Chronic Kidney Disease
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Minimal Hepatic Encephalopathy
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    Chemotherapy-induced Diarrhea
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
        8.6.4    Pathogen Related Infections
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2016-2020)
            8.6.4.3    Forecast Trend (2021-2026)
        8.6.5    Diabetic Neuropathy
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2016-2020)
            8.6.5.3    Forecast Trend (2021-2026)
        8.6.6    ADHD
            8.6.6.1    Market Share
            8.6.6.2    Historical Trend (2016-2020)
            8.6.6.3    Forecast Trend (2021-2026)
        8.6.7    Depression
            8.6.7.1    Market Share
            8.6.7.2    Historical Trend (2016-2020)
            8.6.7.3    Forecast Trend (2021-2026)
        8.6.8    Alzheimer’s Disease
            8.6.8.1    Market Share
            8.6.8.2    Historical Trend (2016-2020)
            8.6.8.3    Forecast Trend (2021-2026)
        8.6.9    Nutritional Deficiency
            8.6.9.1    Market Share
            8.6.9.2    Historical Trend (2016-2020)
            8.6.9.3    Forecast Trend (2021-2026)
        8.6.10    Orphan Disease
            8.6.10.1    Market Share
            8.6.10.2    Historical Trend (2016-2020)
            8.6.10.3    Forecast Trend (2021-2026)
            8.6.10.4    Breakup by Type
                8.6.10.4.1    Phenylketonuria
                8.6.10.4.2    Eosinophilic Esophagitis
                8.6.10.4.3    FPIES
                8.6.10.4.4    Others 
        8.6.11    Others
    8.7    Global Medical Foods Market by Sales Channel
        8.7.1    Online Sales
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2016-2020)
            8.7.1.3    Forecast Trend (2021-2026)
        8.7.2    Institutional Sales
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2016-2020)
            8.7.2.3    Forecast Trend (2021-2026)
        8.7.3    Retail Sales
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2016-2020)
            8.7.3.3    Forecast Trend (2021-2026)
    8.8    Global Medical Foods Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price 
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Danone S.A
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Nestle S.A
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3     Abbott Nutrition
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Targeted Medical Pharma Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Primus Pharmaceuticals, Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments


List of Figures and Tables 

1.    Global Medical Foods Market: Key Industry Highlights, 2016 and 2026
2.    Global Medical Foods Historical Market: Breakup by Route of Administration (USD Billion), 2016-2020
3.    Global Medical Foods Market Forecast: Breakup by Route of Administration (USD Billion), 2021-2026
4.    Global Medical Foods Historical Market: Breakup by Product (USD Billion), 2016-2020
5.    Global Medical Foods Market Forecast: Breakup by Product (USD Billion), 2021-2026
6.    Global Medical Foods Historical Market: Breakup by Application (USD Billion), 2016-2020
7.    Global Medical Foods Market Forecast: Breakup by Application (USD Billion), 2021-2026
8.    Global Medical Foods Historical Market: Breakup by Sales Channel (USD Billion), 2016-2020
9.    Global Medical Foods Market Forecast: Breakup by Sales Channel (USD Billion), 2021-2026
10.    Global Medical Foods Historical Market: Breakup by Region (USD Billion), 2016-2020
11.    Global Medical Foods Market Forecast: Breakup by Region (USD Billion), 2021-2026
12.    North America Medical Foods Historical Market: Breakup by Country (USD Billion), 2016-2020
13.    North America Medical Foods Market Forecast: Breakup by Country (USD Billion), 2021-2026
14.    Europe Medical Foods Historical Market: Breakup by Country (USD Billion), 2016-2020
15.    Europe Medical Foods Market Forecast: Breakup by Country (USD Billion), 2021-2026
16.    Asia Pacific Medical Foods Historical Market: Breakup by Country (USD Billion), 2016-2020
17.    Asia Pacific Medical Foods Market Forecast: Breakup by Country (USD Billion), 2021-2026
18.    Latin America Medical Foods Historical Market: Breakup by Country (USD Billion), 2016-2020
19.    Latin America Medical Foods Market Forecast: Breakup by Country (USD Billion), 2021-2026
20.    Middle East and Africa Medical Foods Historical Market: Breakup by Country (USD Billion), 2016-2020
21.    Middle East and Africa Medical Foods Market Forecast: Breakup by Country (USD Billion), 2021-2026
22.    Global Medical Foods Market Structure

Key Questions Answered in the Report

In 2020, the global medical foods market attained a value of nearly USD 21 billion.

The market is projected to grow at a CAGR of 6.0% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach USD 27.8 billion by 2026.

The major drivers of the industry, such as the increased demand for medical foods in the treatment of various diseases, health issues caused by unhealthy diet and sedentary lifestyle, rising consciousness among consumers regarding health and well-being, and the increasing investments in research and development activities by the leading manufacturers, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the increased incidences of chronic diseases and the rising awareness about medical foods.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The significant routes of administration include oral and enteral.

The significant product types include pills, powders, and others.

The major applications include chronic kidney disease, minimal hepatic encephalopathy, chemotherapy-induced diarrhea, pathogen related infections, diabetic neuropathy, ADHD, depression, Alzheimer’s disease, nutritional deficiency, orphan disease and others.

The significant sales channels include online sales, institutional sales, and retail sales.

The major players in the industry are Danone S.A, Nestle S.A, Abbott Nutrition, Targeted Medical Pharma Inc., Primus Pharmaceuticals, Inc., and others.

Analyst Review

The global medical foods market attained a value of USD 21 billion in 2020, driven by the increased incidences of chronic diseases. Aided by the rising awareness regarding the importance of medical foods in treatment procedures and patient recovery, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 6.0%. The market is projected to reach USD 27.8 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. On the basis of route of administration, the market can be distributed into oral and enteral. By product type, the industry can be segmented into pills, powders, and others. On the basis of application, the market can be categorised into chronic kidney disease, minimal hepatic encephalopathy, chemotherapy-induced diarrhea, pathogen related infections, diabetic neuropathy, ADHD, depression, Alzheimer’s disease, nutritional deficiency, orphan disease, and others. Based on sales channels, the industry can be segregated into online sales, institutional sales, and retail sales. The major regional markets for medical foods are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Danone S.A, Nestle S.A, Abbott Nutrition, Targeted Medical Pharma Inc., Primus Pharmaceuticals, Inc., and others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER